...
首页> 外文期刊>Journal of vascular surgery >Endoleak management and postoperative surveillance following endovascular repair of thoracic aortic aneurysms
【24h】

Endoleak management and postoperative surveillance following endovascular repair of thoracic aortic aneurysms

机译:胸腔主动脉瘤血管内修复后的肠胃管理和术后监测

获取原文
获取原文并翻译 | 示例
           

摘要

As with endovascular repair of abdominal aortic aneurysms (EVAR), thoracic endovascular aortic repair (TEVAR) has become an accepted and preferred alternative to open surgical repair for the treatment of thoracic aortic aneurysms (TAAs). The incidence of TAAs is approximately 6/100,000 person-years, the risk of rupture for large TAAs is as high as 74% without repair, and >90% of patients do not survive a ruptured TAA. TEVAR offers the potential for aneurysm exclusion while avoiding a thoracotomy and aortic cross-clamping as well as the increased morbidity and mortality associated with open surgical repair. Unlike the minimal imaging required after open repair, however, patients undergoing TEVAR require lifelong postoperative surveillance imaging to detect some of the complications unique to EVAR. These include endoleak formation, endograft migration, endograft fracture, and aortic neck dilatation. (See the article by Drs Halandras and Milner for a more detailed description of late complications other than endoleak.) Although the detection and management of endoleaks after EVAR has been well documented, less has been reported about endoleaks after TEVAR. Despite recent advances in endovascular technology, endoleaks (primarily proximal type I endoleaks) remain an Achilles' heel of endovascular TAA repair because of the challenge of achieving a proximal seal between the endograft and the distal aortic arch. This article will address the incidence, mechanisms, and risk factors for endoleak formation after TEVAR, and will present the strategies and results for endoleak management and treatment as well as recommendations for surveillance imaging after TEVAR.
机译:与腹部主动脉瘤(EVAR)的血管内修复一样,胸腔血管内主动脉修复(TEVAR)已成为公开和优选的替代方案,用于打开治疗胸主动脉瘤(TAAS)的手术修复。 TAA的发病率约为6 / 100,000人 - 年,大TAA破裂的风险高达74%而无需修复,并且> 90%的患者不会在一个破裂的TAA中存活。 Tevar提供动脉瘤排除的可能性,同时避免了胸廓切开术和主动脉交叉夹紧以及与开放手术修复相关的发病率和死亡率增加。然而,与开放修复后所需的最小成像不同,接受TEVAR的患者需要终身术后监测成像,以检测evar具有独特的一些并发症。这些包括胚胎形成,内血症移植迁移,内血症裂缝和主动脉颈部扩张。 (请参阅Drs Halandras和Milner的文章,以更详细地描述endoleak以外的后期并发症。)虽然Evar在evar经过充分记录后的延展闹剧的检测和管理,但Tevar之后的螺氧凹陷较少。尽管最近的血管内技术进展,但由于在内血症和远端主动脉弓之间实现了近端密封,延长牛排(主要近端I odeoheaks)仍然是血管内腹腔罩修复的Achilles的脚跟。本文将在TEVAR之后讨论止回阀形成的发病率,机制和危险因素,并将展示Endoleak管理和待遇的策略和结果以及Tevar后监测成像的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号